Barclays European Morning Research Summary

Research evidence excerpt

Barclays European Morning Research Summary

ned by Section 270.24(b) of the US Investment Company Act of 1940, nor is it

intended to constitute an offer, promotion or recommendation of, and should not be viewed as marketing (including, without limitation, for the

purposes of the UK Alternative Investment Fund Managers Regulations 2013 (SI 2013/1773) or AIFMD (Directive 2011/61)) or pre-marketing

(including, without limitation, for the purposes of Directive (EU) 2019/1160) of the securities, products or issuers that are the subject of this report.

Third Party Distribution: Any views expressed in this communication are solely those of Barclays and have not been adopted or endorsed by any

third party distributor.

United Kingdom: This document is being distributed (1) only by or with the approval of an authorised person (Barclays Bank PLC) or (2) to, and is

directed at (a) persons in the United Kingdom having professional experience in matters relating to investments and who fall within the definition of

"investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (b)

high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order;

or (c) other persons to whom it may otherwise lawfully be communicated (all such persons being "Relevant Persons"). Any investment or investment

activity to which this communication relates is only available to and will only be engaged in with Relevant Persons. Any other persons who receive

this communication should not rely on or act upon it. Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the